We identified six publications, with one conference abstract [23] in addition (Figure 2); four publications reported co-occurring IDH1/2 mutations in acute myeloid leukaemia (AML) [22,23,24,25], 1 in chondrosarcoma [26] and 1 in glioma [27]. Here, IDH1 is linked to acute myeloid leukemia.